304 related articles for article (PubMed ID: 25971554)
1. Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.
O'Shannessy DJ; Somers EB; Wang LC; Wang H; Hsu R
J Ovarian Res; 2015 May; 8():29. PubMed ID: 25971554
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.
O'Shannessy DJ; Jackson SM; Twine NC; Hoffman BE; Dezso Z; Agoulnik SI; Somers EB
Int J Mol Sci; 2013 Jul; 14(7):13687-703. PubMed ID: 23880844
[TBL] [Abstract][Full Text] [Related]
3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
4. Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma.
Hua Y; Choi PW; Trachtenberg AJ; Ng AC; Kuo WP; Ng SK; Dinulescu DM; Matzuk MM; Berkowitz RS; Ng SW
Oncotarget; 2016 Oct; 7(40):66077-66086. PubMed ID: 27602775
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer and normal fallopian tube high WFDC2 expression does not correlate with HE4 serum level.
Gąsiorowska E; Walkowiak GP; Warchoł W; Lemańska A; Jankowska A; Nowak-Markwitz E
Ginekol Pol; 2015 May; 86(5):335-9. PubMed ID: 26117969
[TBL] [Abstract][Full Text] [Related]
6. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
7. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
Chen Y; Zhang L; Lv R; Zhang WQ
Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
[TBL] [Abstract][Full Text] [Related]
10. Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients.
Paradowska E; Jabłońska A; Studzińska M; Wilczyński M; Wilczyński JR
Sci Rep; 2019 Dec; 9(1):19935. PubMed ID: 31882737
[TBL] [Abstract][Full Text] [Related]
11. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy.
Despierre E; Lambrechts S; Leunen K; Berteloot P; Neven P; Amant F; O'Shannessy DJ; Somers EB; Vergote I
Gynecol Oncol; 2013 Jul; 130(1):192-9. PubMed ID: 23558051
[TBL] [Abstract][Full Text] [Related]
13. Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor type.
O'Shannessy DJ; Somers EB; Smale R; Fu YS
Int J Gynecol Pathol; 2013 May; 32(3):258-68. PubMed ID: 23518909
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of the Mac-1 expression on peripheral blood neutrophils in patients with different types of epithelial ovarian cancer.
Bednarska K; Klink M; Wilczyński JR; Szyłło K; Malinowski A; Sułowska Z; Nowak M
Immunobiology; 2016 Feb; 221(2):323-32. PubMed ID: 26563750
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.
Notaro S; Reimer D; Fiegl H; Schmid G; Wiedemair A; Rössler J; Marth C; Zeimet AG
BMC Cancer; 2016 Aug; 16():589. PubMed ID: 27485273
[TBL] [Abstract][Full Text] [Related]
17. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
[TBL] [Abstract][Full Text] [Related]
18. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
19. Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma.
Gurler H; Macias V; Kajdacsy-Balla AA; Barbolina MV
Biomolecules; 2015 Dec; 5(4):3438-47. PubMed ID: 26633537
[TBL] [Abstract][Full Text] [Related]
20. Role of Fallopian Tubes in the Development of Ovarian Cancer.
Corzo C; Iniesta MD; Patrono MG; Lu KH; Ramirez PT
J Minim Invasive Gynecol; 2017 Feb; 24(2):230-234. PubMed ID: 28007588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]